Immunic IMUX Stock
Immunic Price Chart
Immunic IMUX Financial and Trading Overview
| Immunic stock price | 14.1 USD |
| Previous Close | 13.97 USD |
| Open | 14.1 USD |
| Bid | 10.26 USD x 200 |
| Ask | 17.92 USD x 200 |
| Day's Range | 13.83 - 14.17 USD |
| 52 Week Range | 5.06 - 15.84 USD |
| Volume | 35.01K USD |
| Avg. Volume | 212.62K USD |
| Market Cap | 191.31M USD |
| Beta (5Y Monthly) | 1.375 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.77 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 41.9 USD |
IMUX Valuation Measures
| Enterprise Value | 4.08M USD |
| Trailing P/E | N/A |
| Forward P/E | -3.8644195 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2649735 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.037 |
Trading Information
Immunic Stock Price History
| Beta (5Y Monthly) | 1.375 |
| 52-Week Change | 42.84% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 15.84 USD |
| 52 Week Low | 5.06 USD |
| 50-Day Moving Average | 14.19 USD |
| 200-Day Moving Average | 10.08 USD |
IMUX Share Statistics
| Avg. Volume (3 month) | 212.62K USD |
| Avg. Daily Volume (10-Days) | 127.98K USD |
| Shares Outstanding | 13.62M |
| Float | 11.84M |
| Short Ratio | 7.81 |
| % Held by Insiders | 0.97% |
| % Held by Institutions | 46.81% |
| Shares Short | 1.41M |
| Short % of Float | 10.97% |
| Short % of Shares Outstanding | 10.38% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -65.18% |
| Return on Equity (ttm) | -142.91% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -109480000 USD |
| Net Income Avi to Common (ttm) | -104287000 USD |
| Diluted EPS (ttm) | -4.77 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 186.63M USD |
| Total Cash Per Share (mrq) | 13.7 USD |
| Total Debt (mrq) | 421K USD |
| Total Debt/Equity (mrq) | 0.28 USD |
| Current Ratio (mrq) | 4.92 |
| Book Value Per Share (mrq) | 11.103 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -81331000 USD |
| Levered Free Cash Flow (ttm) | -41392752 USD |
Profile of Immunic
| Country | United States |
| State | NY |
| City | New York |
| Address | 1200 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 332 255 9818 |
| Website | https://imux.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 95 |
Immunic, Inc., a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company also develops IMU-856, which is entering Phase 2 clinical trial, for the restoration of the intestinal barrier function in patients suffering from gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, short bowel syndrome, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases; and IMU-381, which is in preclinical trial, for the treatment of gastrointestinal diseases. Immunic, Inc. was founded in 2016 and is headquartered in New York, New York.
Q&A For Immunic Stock
What is a current IMUX stock price?
Immunic IMUX stock price today per share is 14.1 USD.
How to purchase Immunic stock?
You can buy IMUX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immunic?
The stock symbol or ticker of Immunic is IMUX.
Which industry does the Immunic company belong to?
The Immunic industry is Biotechnology.
How many shares does Immunic have in circulation?
The max supply of Immunic shares is 13.62M.
What is Immunic Price to Earnings Ratio (PE Ratio)?
Immunic PE Ratio is now.
What was Immunic earnings per share over the trailing 12 months (TTM)?
Immunic EPS is -4.77 USD over the trailing 12 months.
Which sector does the Immunic company belong to?
The Immunic sector is Healthcare.
Immunic IMUX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25913.9 USD — |
+2.13
|
10.13B USD — | 25420.35 USD — | 25967.44 USD — | — - | 10.13B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12723.95 USD — |
+2.13
|
— — | 12482.68 USD — | 12751.18 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6431.2 USD — |
-0.34
|
— — | 6381.13 USD — | 6469.08 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1241.31 USD — |
+0.58
|
— — | 1233.81 USD — | 1244.91 USD — | — - | — — |
|
US Tech Capital Market Composite
RCMP
US
|
137.57 USD — |
+2.45
|
— — | 133.6 USD — | 137.82 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}
